GlaxoSmithKline, Alphabet create $715 million bioelectronics firm
GlaxoSmithKline and Alphabet`s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics.